A multicenter case-control study of the effect of acute rejection and cytomegalovirus infection on pneumocystis pneumonia in solid organ transplant recipients SM Hosseini-Moghaddam, M Shokoohi, G Singh, SF Dufresne, A Boucher, ... Clinical Infectious Diseases 68 (8), 1320-1326, 2019 | 67 | 2019 |
Pneumocystis jirovecii: a review with a focus on prevention and treatment RB Weyant, D Kabbani, K Doucette, C Lau, C Cervera Expert opinion on pharmacotherapy 22 (12), 1579-1592, 2021 | 66 | 2021 |
Strongyloides stercoralis transmission by kidney transplantation in two recipients from a common donor DA Roseman, D Kabbani, J Kwah, D Bird, R Ingalls, A Gautam, M Nuhn, ... American Journal of Transplantation 13 (9), 2483-2486, 2013 | 45 | 2013 |
Pentraxin 3 levels in bronchoalveolar lavage fluid of lung transplant recipients with invasive aspergillosis D Kabbani, A Bhaskaran, LG Singer, A Bhimji, C Rotstein, S Keshavjee, ... The Journal of Heart and Lung Transplantation 36 (9), 973-979, 2017 | 35 | 2017 |
Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal … B Rammaert, M Puyade, OA Cornely, D Seidel, P Grossi, S Husain, ... Transplant infectious disease 21 (5), e13141, 2019 | 27 | 2019 |
(1, 3) β-D-Glucan in bronchoalveolar lavage of lung transplant recipients for the diagnosis of invasive pulmonary aspergillosis A Bhaskaran, D Kabbani, LG Singer, T Prochnow, A Bhimji, C Rotstein, ... Medical mycology 55 (2), 173-179, 2017 | 21 | 2017 |
Donor graft cytomegalovirus serostatus and the risk of arterial and venous thrombotic events in seronegative recipients after non-thoracic solid organ transplantation S Belga, C MacDonald, D Chiang, D Kabbani, S Shojai, JG Abraldes, ... Clinical Infectious Diseases 72 (5), 845-852, 2021 | 13 | 2021 |
Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non … JZ Chen, HL Hoang, M Yaskina, D Kabbani, KE Doucette, SW Smith, ... The Lancet Infectious Diseases 23 (6), 673-682, 2023 | 12 | 2023 |
The direct and indirect effects of vancomycin-resistant enterococci colonization in liver transplant candidates and recipients S Belga, D Chiang, D Kabbani, JG Abraldes, C Cervera Expert Review of Anti-infective Therapy 17 (5), 363-373, 2019 | 11 | 2019 |
Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis D Kabbani, L Goldraich, H Ross, C Rotstein, S Husain Transplant Infectious Disease 20 (1), e12808, 2018 | 11 | 2018 |
Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from patients newly identified as nasal carriers SK Weir, J Fram, G Berg, D Kabbani, J Strymish, M Tang, D Fitzsimmons, ... Journal of clinical microbiology 50 (10), 3283-3286, 2012 | 9 | 2012 |
Association between gut colonization of vancomycin‐resistant enterococci and liver transplant outcomes D Chiang, TC Dingle, S Belga, D Kabbani, RA Bhanji, J Walter, ... Transplant Infectious Disease 24 (3), e13821, 2022 | 8 | 2022 |
Clinical impact of vancomycin‐resistant enterococci colonization in nonliver solid organ transplantation and its implications for infection control strategies: A single‐center … AC McFarlane, D Kabbani, JA Bakal, SW Smith Transplant Infectious Disease 23 (6), 13747, 2021 | 7 | 2021 |
Granuloma in the explanted lungs: Infectious causes and impact on post‐lung transplant mycobacterial infection D Kabbani, HN Kozlowski, C Cervera, C Chaparro, L Singer, C Rotstein, ... Transplant Infectious Disease 22 (3), e13262, 2020 | 7 | 2020 |
Cohorting based on nasal methicillin-resistant Staphylococcus aureus status: an opportunity to share more than a room D Kabbani, SK Weir, G Berg, GC Chien, J Strymish, K Gupta American journal of infection control 41 (5), 401-404, 2013 | 7 | 2013 |
Hepatitis B surface antigen–positive donor to negative recipient lung transplantation S Belga, D Kabbani, K Doucette American Journal of Transplantation 20 (8), 2287-2288, 2020 | 6 | 2020 |
Adjunctive glucocorticoid therapy for Pneumocystis jirovecii pneumonia in solid organ transplant recipients: A multicenter cohort, 2015-2020 SM Hosseini-Moghaddam, S Kothari, A Humar, H Albasata, ZA Yetmar, ... American Journal of Transplantation 24 (4), 653-668, 2024 | 5 | 2024 |
Omicron BA. 4/5 neutralization and T-cell responses in organ transplant recipients after booster messenger RNA vaccine: A multicenter cohort study VH Ferreira, M Ierullo, F Mavandadnejad, A Kurtesi, Q Hu, WR Hardy, ... Clinical Infectious Diseases 77 (2), 229-236, 2023 | 5 | 2023 |
Targeted Prophylaxis to Prevent Late-Onset Pneumocystis jirovecii Pneumonia in Kidney Transplantation: Are We There Yet? C Cervera, M Yaskina, D Kabbani Clinical Infectious Diseases 73 (7), e1464-e1466, 2021 | 5 | 2021 |
2646. Incidence of myelosuppression related to valganciclovir prophylaxis in solid-organ transplant recipients at high risk of CMV disease S Belga, C Hernandez, D Kabbani, C Cervera Open Forum Infectious Diseases 6 (Suppl 2), S925, 2019 | 4 | 2019 |